By analyzing the data of newly diagnosed AML patients from the TCGA and public GEPIA database, we found that only PAK1 is significantly up-regulated in primary AML patients and confers to poor survival of AML compared with other PAK family members. Here, PAK1 is linked to acute myeloid leukemia.